We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




NIH’s Observational Medical Outcomes Partnership Seeks Public Feedback on Research Priorities

By LabMedica International staff writers
Posted on 17 Sep 2012
The Foundation for the US National Institutes of Health (Bethesda, MD, USA) managed Observational Medical Outcomes Partnership (OMOP) is seeking public feedback on proposed research priorities and tasks. More...


OMOP was formed in 2008 to conduct methodologic research to inform the suitable use of observational healthcare data for studying the effects of medical products. OMOP has generated empirical evidence about the performance of observational analysis methods to identify real risks of medical products and discriminate from false findings. The basic goal of this research is to develop and evaluate standardized algorithms that can effectively distinguish positive from negative controls, and to understand how an estimated effect from an observational study relates to the true relationship between medical product exposure and adverse events.

As part of its research, OMOP has developed tools and capabilities for transforming, characterizing, and examining disparate data sources across the healthcare delivery spectrum, and has established a shared resource to enable collaborative research. OMOP’s research continues to reiterate the idea that advancing the science of observational research requires an empirical and reproducible approach to methodology and its systematic application.

To continue the effort, the OMOP executive board proposed a series of priorities, infrastructure tasks, and research tasks to guide the development of OMOP’s research agenda for 2013-2016.

The OMOP executive board is seeking comment on the adequacy and completeness of the research priorities and tasks. “Receiving public feedback regarding OMOP’s work is vital to our success,” said OMOP executive board member, Ronald Krall, MD. “We want to make sure we hear every idea about how to use healthcare data to improve the safety and effectiveness of medical products.”

The proposed research priorities and tasks are found on the OMOP website with instructions on how to provide feedback. Comments can be given through September 15, 2012.

Established by the United States Congress to support the mission of the NIH--improving health through scientific discovery in the search for cure--the Foundation for the NIH is a leader in identifying and addressing complex scientific and health issues.

Related Links:
Foundation for the US National Institutes of Health
Observational Medical Outcomes Partnership


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.